|
Volumn 12, Issue 13, 2011, Pages 2141-2142
|
Current treatment for nonalcoholic fatty liver disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
ATORVASTATIN;
GAMMA GLUTAMYLTRANSFERASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
URIC ACID;
CARDIOVASCULAR RISK;
DISEASE ASSOCIATION;
DRUG EFFICACY;
ENZYME ACTIVITY;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
LIVER FUNCTION TEST;
NONALCOHOLIC FATTY LIVER;
POST HOC ANALYSIS;
RISK FACTOR;
URIC ACID BLOOD LEVEL;
FATTY LIVER;
HUMANS;
|
EID: 80051519045
PISSN: 14656566
EISSN: 17447666
Source Type: Journal
DOI: 10.1517/14656566.2011.604597 Document Type: Letter |
Times cited : (4)
|
References (5)
|